Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion: a Randomized, Open-label, Proof of Concept Study

NCT05512910 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05512910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05512910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion: a Randomized, Open-label, Proof of Concept Study
Lead sponsor
Xijing Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 4, 2023
Completion date
June 4, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basilar artery occlusion, endovascular treatment, ischemic stroke, acute, minocycline